Table 2.
Target species | CoV genus targeted by vaccine | CoV-induced disease | Licensed product | Technology | Formulation |
---|---|---|---|---|---|
Cattle | Betacoronavirus | Gastroenteritis, neonatal calf diarrhoea | Rotavec Corona | Inactivated plus adjuvant | Trivalent (CoV, rotavirus and Escherichia coli) |
Bovigen Scour | Inactivated plus adjuvant | Trivalent (CoV, rotavirus and E. coli) | |||
Calf-Guard | Live attenuated | Bivalent (CoV and rotavirus) | |||
Poultry | Gammacoronavirus | Respiratory disease, reduced egg yields | Nobilis IB + ND + EDS | Live attenuated | Multivalent (infectious bronchitis virus, Newcastle disease virus and egg drop syndrome virus) |
Pigs | Alphacoronavirus G | Gastroenteritis | ProSystem TGE/Rota | Live attenuated | Bivalent (TGE virus and rotavirus) |
Dogs | Alphacoronavirus G | Gastroenteritis | Solo-Jec 6 | Live attenuated plus inactivated plus adjuvant | Multivalent (CoV, adenovirus, parainfluenza virus and parvovirus) |
Nobivac Canine 1-Cv | Inactivated plus adjuvant | Monovalent (CoV) | |||
Cats | Alphacoronavirus G | Peritonitis | Felocell FIP | Live attenuated | Monovalent (FIP virus) |
CoV, coronavirus; FIP, feline infectious peritonitis; TGE, transmissible gastroenteritis.